Company intelligence / Profile preview
AyuVis Research, Inc.
Fort Worth, Texas, United Statesayuvis.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
AyuVis received FDA clearance for its AVR-48 IND application in January 2024 and is proceeding with a Phase 1 clinical trial. The Phase 1 will be a double-blinded, placebo-controlled single ascending dose (SAD) and multiple ascending dose (MAD) study to evaluate safety and tolerability in healthy adult volunteers. Pre-clinical research has shown that AVR-48 can prevent inflammation and tissue damage, promote new lung cell growth, quiet cytokine storms, and remain effective against multi-drug resistant infections[7].
- Therapeutic areas
- GastroenterologyPulmonologyNephrologyOphthalmologyImmunologyInfectious Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Strategic discussions with large pharmaceutical companies are in progress[3]
Beyond the preview
Go deeper on AyuVis Research, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AyuVis Research, Inc..